{"id":2444,"date":"2024-01-02T11:07:51","date_gmt":"2024-01-02T10:07:51","guid":{"rendered":"https:\/\/www.smartagents-healthcare.fr\/?p=2444"},"modified":"2026-04-29T16:22:47","modified_gmt":"2026-04-29T14:22:47","slug":"pharmaceutical-industry-france-opportunities-pharmacies","status":"publish","type":"post","link":"https:\/\/www.smartagents-healthcare.fr\/en\/industrie-pharmaceutique-france-opportunites-officines\/","title":{"rendered":"French pharmaceutical industry in 2026: opportunities for pharmacies and pharmacy groups"},"content":{"rendered":"<p class=\"wp-block-paragraph\">The French pharmaceutical industry is going through a period of profound transformation. Between the relocation of production, the newly expanded roles of pharmacists, and the rise of white-label products, pharmacies and pharmaceutical groups currently have fertile ground to grow their revenue and strengthen their differentiation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This article gives you a clear reading of the market state in 2026 \u2014 with the real figures, regulatory challenges, and above all, the concrete opportunities you can quickly activate as an independent pharmacist or group member.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">1. The French pharmaceutical industry in 2026: key figures<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">France remains one of the major players in the global pharmaceutical industry. Here is the reference data from the\u00a0<a href=\"https:\/\/www.leem.org\/chiffres-cles\">LEEM (The Pharmaceutical Companies of France)<\/a>\u00a0and of the\u2019<a href=\"https:\/\/www.efpia.eu\/publications\/data-center\/\">EFPIA (European Federation of Pharmaceutical Industries and Associations)<\/a> for 2024-2025:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Indicator<\/strong><\/td><td><strong>Figure 2024\u20132025<\/strong><\/td><td><strong>Source<\/strong><\/td><\/tr><tr><td>Total revenue<\/td><td>\u20ac67.5 billion<\/td><td>LEEM 2024<\/td><\/tr><tr><td>Direct jobs<\/td><td>100 000+<\/td><td>LEEM 2024<\/td><\/tr><tr><td>Export share<\/td><td>~75% of revenue<\/td><td>LEEM 2024<\/td><\/tr><tr><td>R&amp;D investment<\/td><td>\u20ac6.5 billion\/year<\/td><td>EFPIA 2024<\/td><\/tr><tr><td>Global ranking<\/td><td>4th largest global exporter<\/td><td>LEEM 2024<\/td><\/tr><tr><td>Number of establishments<\/td><td>270 production sites<\/td><td>LEEM 2024<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><em>France is the world's 4th largest exporter of medicines and the 2nd in Europe behind Germany. The sector accounts for about 2.5% of national GDP according to LEEM.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These figures illustrate a generally healthy sector that is nonetheless undergoing significant structural transformations\u2014notably pricing pressure on generics, the rise of biosimilars, and the relocation of API (Active Pharmaceutical Ingredient) supply chains following post-Covid supply tensions.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">2. The new missions of pharmacists: a direct growth driver<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Since 2023, the duties of community pharmacists have been significantly expanded by law. These new skills create a direct demand for complementary products and medical devices.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2.1 What pharmacists can do in 2026<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Expanded vaccination:\u00a0<\/strong>flu, Covid-19, but also shingles, papillomavirus and soon meningococcus \u2014 requires disinfection and protection consumables<\/li>\n\n\n\n<li><strong>Medication review :\u00a0<\/strong>monitoring of polymedicated patients, management of treatment adherence<\/li>\n\n\n\n<li><strong>Screening and rapid tests:\u00a0<\/strong>strep throat, flu, Covid, STI \u2014 automated testing machines and self-diagnostic devices are becoming essential<\/li>\n\n\n\n<li><strong>Boxed prescription:\u00a0<\/strong>renewal of certain prescriptions, dosage adjustments<\/li>\n\n\n\n<li><strong>Teleconsultation in pharmacy:\u00a0<\/strong>teleconsultation booths, blood pressure monitoring, diabetes<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Each of these missions creates a product need. A pharmacist who vaccinates needs disinfecting wipes, compresses, and saline solution. A pharmacist who does screening needs self-diagnostic devices. That is where the white-label strategy comes in.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To go further on this subject:&nbsp;<a href=\"https:\/\/www.smartagents-healthcare.fr\/en\/new-missions-for-pharmacists-in-2025-opportunities-for-white-label-manufacturers\/\">new pharmacist missions in 2025 and product opportunities \u2192<\/a>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2.2 What this means for groups<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Pharmaceutical groups (Groupama, PHR, Welcoop, Pharmavie, etc.) have every reason to integrate private label product ranges in order to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Strengthen the brand identity of their member pharmacies<\/li>\n\n\n\n<li>Improve margins on high-volume products (saline solution, wipes, compresses)<\/li>\n\n\n\n<li>Respond to new missions without depending on the catalogs of major manufacturers<\/li>\n\n\n\n<li>Differentiating the pharmacy in the face of e-health pure player competition<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">3. The best white-label product opportunities for 2026<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Here are the pharmaceutical and para-pharmaceutical products offering the best potential-to-accessibility ratio for a pharmacy or pharmacy group wishing to launch its own brand:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Product<\/strong><\/td><td><strong>Market potential<\/strong><\/td><td><strong>Level of competition<\/strong><\/td><td><strong>Launch time<\/strong><\/td><\/tr><tr><td>Physiological serum<\/td><td>Very high<\/td><td>Average<\/td><td>6\u201310 weeks<\/td><\/tr><tr><td>Disinfecting wipes<\/td><td>High<\/td><td>Average<\/td><td>8 to 12 weeks<\/td><\/tr><tr><td>Cotton pads \/ gauze pads<\/td><td>High<\/td><td>Weak<\/td><td>6\u20138 weeks<\/td><\/tr><tr><td>Self-diagnostic devices<\/td><td>Very high<\/td><td>High<\/td><td>12\u201316 weeks<\/td><\/tr><tr><td>Medical nebulizers<\/td><td>Average<\/td><td>Weak<\/td><td>10\u201314 weeks<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">3.1 White-label saline solution<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">It is the easiest product to launch and the most profitable by volume. Demand is steady, margins are good on the 500 ml bottle format, and the regulations are well-managed. A group of 50 pharmacies can order starting from 16,000 units and offer their own saline solution under their own brand in 6 to 10 weeks.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Discover our offer:&nbsp;<a href=\"https:\/\/www.smartagents-healthcare.fr\/en\/physiological-serum\/\">private label saline solution<\/a>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3.2 Professional disinfecting wipes<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">With the expansion of vaccination and screening missions, disinfecting wipes have become a primary consumable in pharmacies. Margins on the 40\/100-unit box formats are significant, and the product differentiates itself well through certification (EN 14476 virucidal).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Learn more:&nbsp;<a href=\"https:\/\/www.smartagents-healthcare.fr\/en\/professional-disinfecting-wipe\/\">professional disinfecting wipe<\/a>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3.3 Sterile cotton gauze pads and squares<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">As fast-moving pharmacy products, compresses and cotton pads are often bought as national brands, whereas private labels allow for margins that are 30 to 50% higher at equivalent volumes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Compare options:&nbsp;<a href=\"https:\/\/www.smartagents-healthcare.fr\/en\/cotton-pads-vs-sterile-gauze-how-to-choose\/\">cotton pads vs. sterile gauze pads \u2192<\/a>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3.4 Self-diagnostic devices<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Rapid diagnostic orientation tests (TROD), blood pressure monitors, connected thermometers, oximeters \u2014 this segment has been growing strongly since 2020 and pharmacists are now at the center of the local healthcare pathway.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Our complete analysis:&nbsp;<a href=\"https:\/\/www.smartagents-healthcare.fr\/en\/self-diagnosis-in-pharmacies-what-medical-devices-to-offer\/\">self-testing in pharmacies: which devices to offer<\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">4. Regulations: what pharmacies need to know in 2026<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">4.1 The regulatory framework for white-label products<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Offering private label products does not mean ignoring the regulatory framework \u2014 quite the contrary. Each product category is subject to specific rules:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>OTC medications:\u00a0<\/strong>Mandatory MA (Marketing Authorization), issued by\u2019<a href=\"https:\/\/ansm.sante.fr\/\">ANSM<\/a>\u00a0\u2014 generally not applicable in direct white label<\/li>\n\n\n\n<li><strong>Medical devices:\u00a0<\/strong>compliance with\u00a0<a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/FR\/TXT\/?uri=CELEX%3A32017R0745\">MDR 2017\/745 regulation<\/a>\u00a0mandatory (CE marking)<\/li>\n\n\n\n<li><strong>Biocidal products (disinfectant wipes):\u00a0<\/strong>compliance with\u00a0<a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/FR\/TXT\/?uri=CELEX%3A32012R0528\">EU Regulation 528\/2012<\/a>\u00a0and EN standards<\/li>\n\n\n\n<li><strong>Cosmetic products (baby wipes, skincare):\u00a0<\/strong>EU cosmetics regulation 1223\/2009, CPNP notification<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">4.2 Reshoring production: A strategic opportunity<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Since the Innovative Health 2030 plan launched by the French government, the relocation of pharmaceutical production to France and Europe has been a national priority. This translates into:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Subsidies and investment aid for French manufacturers<\/li>\n\n\n\n<li>A growing preference among public and hospital buyers for Made in Europe products<\/li>\n\n\n\n<li>Securing supplies for pharmacies working with local manufacturers<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Smart Agents Healthcare is part of this local production logic, with ISO 13485 certified manufacturing partners based in France and Europe.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">5. FAQ \u2014 Frequently asked questions about the pharmaceutical industry and pharmacy private labels<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1777459548136\"><strong class=\"schema-faq-question\">How many pharmaceutical laboratories are there in France?<\/strong> <p class=\"schema-faq-answer\">According to\u00a0<a href=\"https:\/\/www.leem.org\/chiffres-cles\">LEEM<\/a>, France has approximately 270 pharmaceutical production sites and more than 300 member companies. The sector directly employs more than 100,000 people, making the pharmaceutical industry one of the country's leading industrial employers.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1777459569263\"><strong class=\"schema-faq-question\">What is the turnover of the French pharmaceutical industry in 2025?<\/strong> <p class=\"schema-faq-answer\">The French pharmaceutical industry generated a turnover of around 67.5 billion euros in 2024, with about 75% coming from exports. France positions itself as the 4th largest global exporter of medicines according to data from LEEM and EFPIA.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1777459595035\"><strong class=\"schema-faq-question\">What is private labeling in pharmacy and how does it work?<\/strong> <p class=\"schema-faq-answer\">White labeling (or private labeling) involves a pharmacy or pharmacy group marketing products manufactured by a third party under its own brand. The manufacturer handles production, certification, and regulatory compliance. The pharmacy chooses the packaging, brand name, and positioning. This is a common strategy in mass retail and has been growing strongly in pharmacies since 2020.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1777459684978\"><strong class=\"schema-faq-question\">What white-label products can be offered in a pharmacy?<\/strong> <p class=\"schema-faq-answer\">Aside from prescription drugs, the vast majority of parapharmacy products, Class I and IIa medical devices, biocidal products, and dietary supplements can be offered under a private label. The most common products are saline solution, wipes, compresses, thermometers, blood pressure monitors, and oximeters.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1777459724948\"><strong class=\"schema-faq-question\">What is the minimum order quantity to launch a white label range?<\/strong> <p class=\"schema-faq-answer\">Minimums vary depending on products and manufacturers. At Smart Agents Healthcare, the minimum order quantity is 16,000 units for saline solution, with development and delivery lead times of 6 to 12 weeks depending on the product. Lower volumes can be considered for buying groups or multi-product orders.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1777459765045\"><strong class=\"schema-faq-question\">Is pharmaceutical relocation an opportunity for French pharmacies?<\/strong> <p class=\"schema-faq-answer\">Yes. The Innovative Medicines 2030 government plan and post-Covid supply chain strains have created a favorable dynamic for French manufacturers and distributors. Pharmacies that source from certified French or European manufacturers benefit from better traceability, secure lead times, and a local commercial argument appreciated by patients.<\/p> <\/div> <\/div>\n\n\n\n<h2 class=\"wp-block-heading\">6. Going further <\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Our practical guides for pharmacies and pharmacy groups: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.smartagents-healthcare.fr\/en\/what-is-the-best-pharmaceutical-product-to-offer-today\/\">What is the best pharma product to offer in 2026?<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.smartagents-healthcare.fr\/en\/physiological-serum\/\">Private label saline solution: manufacturing, standards, and customization<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.smartagents-healthcare.fr\/en\/professional-disinfecting-wipe\/\">Professional disinfecting wipe: how to choose in 2026?<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.smartagents-healthcare.fr\/en\/self-diagnosis-in-pharmacies-what-medical-devices-to-offer\/\">Self-diagnosis in pharmacies: what medical devices are available?<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.smartagents-healthcare.fr\/en\/who-are-the-best-white-label-pharmaceutical-manufacturers\/\">Who are the best private label pharmaceutical manufacturers?<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.smartagents-healthcare.fr\/en\/white-label-pharmaceutical-packaging-design-reliable-and-compliant-packaging-for-the-french-market\/\">White-label pharma packaging: designing reliable and compliant packaging<\/a><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Institutional references:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.leem.org\/chiffres-cles\">LEEM \u2014 Key figures of the French pharmaceutical industry<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/ansm.sante.fr\/\">ANSM \u2014 National Agency for Medicines Safety<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.efpia.eu\/publications\/data-center\/\">EFPIA \u2014 European Pharmaceutical Industry Data<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/FR\/TXT\/?uri=CELEX%3A32017R0745\">MDR 2017\/745 Regulation on Medical Devices<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.gouvernement.fr\/medicaments-innovants\">Innovative Medicines Plan 2030 \u2014 French Government<\/a><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The French pharmaceutical industry in 2026 offers pharmacies and pharmacy groups a particularly favorable context to develop their own brand lines: newly expanded missions for pharmacists, relocation momentum, and growing patient demand for local and traceable products.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Private labeling is no longer reserved for large groups. With the right certified manufacturing partners, an independent pharmacy can launch its first product line in less than 3 months, focusing on high-potential products such as saline solution, disinfectant wipes, or sterile compresses.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u27a1&nbsp;<\/strong><a href=\"https:\/\/www.smartagents-healthcare.fr\/en\/contact-us\/\">Contact Smart Agents Healthcare to discuss your white-label product line project \u2192<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The French pharmaceutical industry is undergoing a period of profound transformation. With the relocation of production, the expanded responsibilities of pharmacists, and the rise of branded products, pharmacies and pharmaceutical groups now have fertile ground to grow their revenue and strengthen their differentiation. This article provides a clear overview of\u2026<\/p>","protected":false},"author":1,"featured_media":2447,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_monsterinsights_skip_tracking":false,"_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"normal","_kad_post_sidebar_id":"","_kad_post_content_style":"unboxed","_kad_post_vertical_padding":"hide","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[10],"tags":[],"class_list":["post-2444","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sante"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Industrie pharmaceutique fran\u00e7aise en 2026 : opportunit\u00e9s pour les officines et groupements<\/title>\n<meta name=\"description\" content=\"Panorama complet de l&#039;industrie pharmaceutique fran\u00e7aise : chiffre d&#039;affaires, principaux laboratoires, enjeux r\u00e9glementaires et opportunit\u00e9s pour les fabricants en marque blanche.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.smartagents-healthcare.fr\/en\/pharmaceutical-industry-france-opportunities-pharmacies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Industrie pharmaceutique fran\u00e7aise en 2026 : opportunit\u00e9s pour les officines et groupements\" \/>\n<meta property=\"og:description\" content=\"Panorama complet de l&#039;industrie pharmaceutique fran\u00e7aise : chiffre d&#039;affaires, principaux laboratoires, enjeux r\u00e9glementaires et opportunit\u00e9s pour les fabricants en marque blanche.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.smartagents-healthcare.fr\/en\/pharmaceutical-industry-france-opportunities-pharmacies\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-02T10:07:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-29T14:22:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.smartagents-healthcare.fr\/wp-content\/uploads\/2024\/07\/lindustrie-pharmaceutique-en-france-9629685-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1707\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9quipe Smart Agents Healthcare\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9quipe Smart Agents Healthcare\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/\"},\"author\":{\"name\":\"\u00c9quipe Smart Agents Healthcare\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/#\\\/schema\\\/person\\\/5c1aeda0baafe20870ec022904b07c89\"},\"headline\":\"Industrie pharmaceutique fran\u00e7aise en 2026 : opportunit\u00e9s pour les officines et groupements\",\"datePublished\":\"2024-01-02T10:07:51+00:00\",\"dateModified\":\"2026-04-29T14:22:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/\"},\"wordCount\":1675,\"publisher\":{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/lindustrie-pharmaceutique-en-france-9629685-scaled.jpg?wsr\",\"articleSection\":[\"Sant\u00e9\"],\"inLanguage\":\"en-US\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/\",\"url\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/\",\"name\":\"Industrie pharmaceutique fran\u00e7aise en 2026 : opportunit\u00e9s pour les officines et groupements\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/lindustrie-pharmaceutique-en-france-9629685-scaled.jpg?wsr\",\"datePublished\":\"2024-01-02T10:07:51+00:00\",\"dateModified\":\"2026-04-29T14:22:47+00:00\",\"description\":\"Panorama complet de l'industrie pharmaceutique fran\u00e7aise : chiffre d'affaires, principaux laboratoires, enjeux r\u00e9glementaires et opportunit\u00e9s pour les fabricants en marque blanche.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#breadcrumb\"},\"mainEntity\":[{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459548136\"},{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459569263\"},{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459595035\"},{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459684978\"},{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459724948\"},{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459765045\"}],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/lindustrie-pharmaceutique-en-france-9629685-scaled.jpg?wsr\",\"contentUrl\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/lindustrie-pharmaceutique-en-france-9629685-scaled.jpg?wsr\",\"width\":1707,\"height\":2560,\"caption\":\"L'industrie pharmaceutique en France\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sant\u00e9\",\"item\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/category\\\/sante\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Industrie pharmaceutique fran\u00e7aise en 2026 : opportunit\u00e9s pour les officines et groupements\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/#website\",\"url\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/\",\"name\":\"Smartagents-healthcare\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/#organization\",\"name\":\"Smartagents-healthcare\",\"url\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/cropped-Smart-Agents-1.png?wsr\",\"contentUrl\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/cropped-Smart-Agents-1.png?wsr\",\"width\":1935,\"height\":323,\"caption\":\"Smartagents-healthcare\"},\"image\":{\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/fr.linkedin.com\\\/company\\\/smart-agents-healthcare?trk=ppro_cprof\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/#\\\/schema\\\/person\\\/5c1aeda0baafe20870ec022904b07c89\",\"name\":\"\u00c9quipe Smart Agents Healthcare\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/989fd557fcb07cfabc0816fa670077e6e7f9714be9c970085874066131a207c3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/989fd557fcb07cfabc0816fa670077e6e7f9714be9c970085874066131a207c3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/989fd557fcb07cfabc0816fa670077e6e7f9714be9c970085874066131a207c3?s=96&d=mm&r=g\",\"caption\":\"\u00c9quipe Smart Agents Healthcare\"},\"description\":\"L'\u00e9quipe de Smart Agents Healthcare r\u00e9unit les p\u00f4les produit et r\u00e9glementaire de SAH, distributeur de dispositifs m\u00e9dicaux et de produits de sant\u00e9 en marque blanche pour les pharmacies, groupements et r\u00e9partiteurs. Nos contenus s'appuient sur notre connaissance des circuits officinaux, des exigences r\u00e9glementaires (r\u00e8glement MDR, norme ISO 13485) et des r\u00e8gles de remboursement (LPP), et sont relus pour en garantir l'exactitude. Ils ont une vocation informative et ne remplacent pas l'avis d'un professionnel de sant\u00e9.\",\"sameAs\":[\"https:\\\/\\\/www.smartagents-healthcare.fr\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/smart-agents-healthcare\\\/\"]},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459548136\",\"position\":1,\"url\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459548136\",\"name\":\"Combien y a-t-il de laboratoires pharmaceutiques en France ?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Selon le\u00a0<a href=\\\"https:\\\/\\\/www.leem.org\\\/chiffres-cles\\\">LEEM<\\\/a>, la France compte environ 270 sites de production pharmaceutique et plus de 300 entreprises membres. Le secteur emploie directement plus de 100 000 personnes, faisant de l'industrie pharmaceutique l'un des premiers employeurs industriels du pays.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459569263\",\"position\":2,\"url\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459569263\",\"name\":\"Quel est le chiffre d'affaires de l'industrie pharmaceutique fran\u00e7aise en 2025 ?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"L'industrie pharmaceutique fran\u00e7aise a r\u00e9alis\u00e9 un chiffre d'affaires de l'ordre de 67,5 milliards d'euros en 2024, dont environ 75% provient des exportations. La France se positionne comme le 4\u00e8me exportateur mondial de m\u00e9dicaments selon les donn\u00e9es du LEEM et de l'EFPIA.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459595035\",\"position\":3,\"url\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459595035\",\"name\":\"Qu'est-ce que la marque blanche en pharmacie et comment \u00e7a fonctionne ?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"La marque blanche (ou marque propre) consiste pour une officine ou un groupement \u00e0 commercialiser des produits fabriqu\u00e9s par un tiers sous sa propre marque. Le fabricant assure la production, la certification et la conformit\u00e9 r\u00e9glementaire. L'officine choisit le packaging, le nom de marque et le positionnement. C'est une strat\u00e9gie courante dans la grande distribution, qui se d\u00e9veloppe fortement en pharmacie depuis 2020.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459684978\",\"position\":4,\"url\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459684978\",\"name\":\"Quels produits peut-on proposer en marque blanche dans une officine ?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"En dehors des m\u00e9dicaments soumis \u00e0 AMM, la grande majorit\u00e9 des produits de parapharmacie, des dispositifs m\u00e9dicaux de classe I et IIa, des produits biocides et des compl\u00e9ments alimentaires peuvent \u00eatre propos\u00e9s en marque propre. Les produits les plus courants sont le s\u00e9rum physiologique, les lingettes, les compresses, les thermom\u00e8tres, les tensiom\u00e8tres et les oxym\u00e8tres.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459724948\",\"position\":5,\"url\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459724948\",\"name\":\"Quel est le minimum de commande pour lancer une gamme en marque blanche ?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Les minima varient selon les produits et les fabricants. Chez Smart Agents Healthcare, le minimum de commande est de 16 000 unit\u00e9s pour le s\u00e9rum physiologique, avec des d\u00e9lais de d\u00e9veloppement et livraison de 6 \u00e0 12 semaines selon le produit. Des volumes plus faibles peuvent \u00eatre \u00e9tudi\u00e9s pour les groupements ou les commandes multi-produits.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459765045\",\"position\":6,\"url\":\"https:\\\/\\\/www.smartagents-healthcare.fr\\\/industrie-pharmaceutique-france-opportunites-officines\\\/#faq-question-1777459765045\",\"name\":\"La relocalisation pharmaceutique est-elle une opportunit\u00e9 pour les officines fran\u00e7aises ?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Oui. Le plan gouvernemental M\u00e9dicaments Innovants 2030 et les tensions d'approvisionnement post-Covid ont cr\u00e9\u00e9 une dynamique favorable aux fabricants et distributeurs fran\u00e7ais. Les officines qui s'approvisionnent aupr\u00e8s de fabricants certifi\u00e9s fran\u00e7ais ou europ\u00e9ens b\u00e9n\u00e9ficient d'une meilleure tra\u00e7abilit\u00e9, de d\u00e9lais s\u00e9curis\u00e9s et d'un argument commercial de proximit\u00e9 appr\u00e9ci\u00e9 des patients.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"French pharmaceutical industry in 2026: opportunities for pharmacies and pharmacy groups","description":"Complete overview of the French pharmaceutical industry: turnover, main laboratories, regulatory challenges, and opportunities for private-label manufacturers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.smartagents-healthcare.fr\/en\/pharmaceutical-industry-france-opportunities-pharmacies\/","og_locale":"en_US","og_type":"article","og_title":"Industrie pharmaceutique fran\u00e7aise en 2026 : opportunit\u00e9s pour les officines et groupements","og_description":"Panorama complet de l'industrie pharmaceutique fran\u00e7aise : chiffre d'affaires, principaux laboratoires, enjeux r\u00e9glementaires et opportunit\u00e9s pour les fabricants en marque blanche.","og_url":"https:\/\/www.smartagents-healthcare.fr\/en\/pharmaceutical-industry-france-opportunities-pharmacies\/","article_published_time":"2024-01-02T10:07:51+00:00","article_modified_time":"2026-04-29T14:22:47+00:00","og_image":[{"width":1707,"height":2560,"url":"https:\/\/www.smartagents-healthcare.fr\/wp-content\/uploads\/2024\/07\/lindustrie-pharmaceutique-en-france-9629685-scaled.jpg","type":"image\/jpeg"}],"author":"\u00c9quipe Smart Agents Healthcare","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9quipe Smart Agents Healthcare","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#article","isPartOf":{"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/"},"author":{"name":"\u00c9quipe Smart Agents Healthcare","@id":"https:\/\/www.smartagents-healthcare.fr\/#\/schema\/person\/5c1aeda0baafe20870ec022904b07c89"},"headline":"Industrie pharmaceutique fran\u00e7aise en 2026 : opportunit\u00e9s pour les officines et groupements","datePublished":"2024-01-02T10:07:51+00:00","dateModified":"2026-04-29T14:22:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/"},"wordCount":1675,"publisher":{"@id":"https:\/\/www.smartagents-healthcare.fr\/#organization"},"image":{"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#primaryimage"},"thumbnailUrl":"https:\/\/www.smartagents-healthcare.fr\/wp-content\/uploads\/2024\/07\/lindustrie-pharmaceutique-en-france-9629685-scaled.jpg?wsr","articleSection":["Sant\u00e9"],"inLanguage":"en-US"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/","url":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/","name":"French pharmaceutical industry in 2026: opportunities for pharmacies and pharmacy groups","isPartOf":{"@id":"https:\/\/www.smartagents-healthcare.fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#primaryimage"},"image":{"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#primaryimage"},"thumbnailUrl":"https:\/\/www.smartagents-healthcare.fr\/wp-content\/uploads\/2024\/07\/lindustrie-pharmaceutique-en-france-9629685-scaled.jpg?wsr","datePublished":"2024-01-02T10:07:51+00:00","dateModified":"2026-04-29T14:22:47+00:00","description":"Complete overview of the French pharmaceutical industry: turnover, main laboratories, regulatory challenges, and opportunities for private-label manufacturers.","breadcrumb":{"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#breadcrumb"},"mainEntity":[{"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459548136"},{"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459569263"},{"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459595035"},{"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459684978"},{"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459724948"},{"@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459765045"}],"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#primaryimage","url":"https:\/\/www.smartagents-healthcare.fr\/wp-content\/uploads\/2024\/07\/lindustrie-pharmaceutique-en-france-9629685-scaled.jpg?wsr","contentUrl":"https:\/\/www.smartagents-healthcare.fr\/wp-content\/uploads\/2024\/07\/lindustrie-pharmaceutique-en-france-9629685-scaled.jpg?wsr","width":1707,"height":2560,"caption":"L'industrie pharmaceutique en France"},{"@type":"BreadcrumbList","@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.smartagents-healthcare.fr\/"},{"@type":"ListItem","position":2,"name":"Sant\u00e9","item":"https:\/\/www.smartagents-healthcare.fr\/category\/sante\/"},{"@type":"ListItem","position":3,"name":"Industrie pharmaceutique fran\u00e7aise en 2026 : opportunit\u00e9s pour les officines et groupements"}]},{"@type":"WebSite","@id":"https:\/\/www.smartagents-healthcare.fr\/#website","url":"https:\/\/www.smartagents-healthcare.fr\/","name":"Smartagents-healthcare","description":"","publisher":{"@id":"https:\/\/www.smartagents-healthcare.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.smartagents-healthcare.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.smartagents-healthcare.fr\/#organization","name":"Smartagents-healthcare","url":"https:\/\/www.smartagents-healthcare.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.smartagents-healthcare.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.smartagents-healthcare.fr\/wp-content\/uploads\/2024\/04\/cropped-Smart-Agents-1.png?wsr","contentUrl":"https:\/\/www.smartagents-healthcare.fr\/wp-content\/uploads\/2024\/04\/cropped-Smart-Agents-1.png?wsr","width":1935,"height":323,"caption":"Smartagents-healthcare"},"image":{"@id":"https:\/\/www.smartagents-healthcare.fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/fr.linkedin.com\/company\/smart-agents-healthcare?trk=ppro_cprof"]},{"@type":"Person","@id":"https:\/\/www.smartagents-healthcare.fr\/#\/schema\/person\/5c1aeda0baafe20870ec022904b07c89","name":"Smart Agents Healthcare Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/989fd557fcb07cfabc0816fa670077e6e7f9714be9c970085874066131a207c3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/989fd557fcb07cfabc0816fa670077e6e7f9714be9c970085874066131a207c3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/989fd557fcb07cfabc0816fa670077e6e7f9714be9c970085874066131a207c3?s=96&d=mm&r=g","caption":"\u00c9quipe Smart Agents Healthcare"},"description":"The Smart Agents Healthcare team brings together the product and regulatory divisions of SAH, a distributor of medical devices and private-label health products for pharmacies, groups, and distributors. Our content is based on our knowledge of the pharmaceutical supply chain, regulatory requirements (MDR regulation, ISO 13485 standard), and reimbursement rules (LPP), and has been reviewed to ensure its accuracy. It is intended for informational purposes only and does not replace the advice of a healthcare professional.","sameAs":["https:\/\/www.smartagents-healthcare.fr","https:\/\/www.linkedin.com\/company\/smart-agents-healthcare\/"]},{"@type":"Question","@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459548136","position":1,"url":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459548136","name":"How many pharmaceutical laboratories are there in France?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Selon le\u00a0<a href=\"https:\/\/www.leem.org\/chiffres-cles\">LEEM<\/a>, la France compte environ 270 sites de production pharmaceutique et plus de 300 entreprises membres. Le secteur emploie directement plus de 100 000 personnes, faisant de l'industrie pharmaceutique l'un des premiers employeurs industriels du pays.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459569263","position":2,"url":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459569263","name":"What is the revenue of the French pharmaceutical industry in 2025?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"L'industrie pharmaceutique fran\u00e7aise a r\u00e9alis\u00e9 un chiffre d'affaires de l'ordre de 67,5 milliards d'euros en 2024, dont environ 75% provient des exportations. La France se positionne comme le 4\u00e8me exportateur mondial de m\u00e9dicaments selon les donn\u00e9es du LEEM et de l'EFPIA.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459595035","position":3,"url":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459595035","name":"What is white labeling in pharmacies and how does it work?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"La marque blanche (ou marque propre) consiste pour une officine ou un groupement \u00e0 commercialiser des produits fabriqu\u00e9s par un tiers sous sa propre marque. Le fabricant assure la production, la certification et la conformit\u00e9 r\u00e9glementaire. L'officine choisit le packaging, le nom de marque et le positionnement. C'est une strat\u00e9gie courante dans la grande distribution, qui se d\u00e9veloppe fortement en pharmacie depuis 2020.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459684978","position":4,"url":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459684978","name":"What white-label products can be offered in a pharmacy?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"En dehors des m\u00e9dicaments soumis \u00e0 AMM, la grande majorit\u00e9 des produits de parapharmacie, des dispositifs m\u00e9dicaux de classe I et IIa, des produits biocides et des compl\u00e9ments alimentaires peuvent \u00eatre propos\u00e9s en marque propre. Les produits les plus courants sont le s\u00e9rum physiologique, les lingettes, les compresses, les thermom\u00e8tres, les tensiom\u00e8tres et les oxym\u00e8tres.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459724948","position":5,"url":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459724948","name":"What is the minimum order quantity to launch a white label range?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Les minima varient selon les produits et les fabricants. Chez Smart Agents Healthcare, le minimum de commande est de 16 000 unit\u00e9s pour le s\u00e9rum physiologique, avec des d\u00e9lais de d\u00e9veloppement et livraison de 6 \u00e0 12 semaines selon le produit. Des volumes plus faibles peuvent \u00eatre \u00e9tudi\u00e9s pour les groupements ou les commandes multi-produits.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459765045","position":6,"url":"https:\/\/www.smartagents-healthcare.fr\/industrie-pharmaceutique-france-opportunites-officines\/#faq-question-1777459765045","name":"Is pharmaceutical relocation an opportunity for French pharmacies?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Oui. Le plan gouvernemental M\u00e9dicaments Innovants 2030 et les tensions d'approvisionnement post-Covid ont cr\u00e9\u00e9 une dynamique favorable aux fabricants et distributeurs fran\u00e7ais. Les officines qui s'approvisionnent aupr\u00e8s de fabricants certifi\u00e9s fran\u00e7ais ou europ\u00e9ens b\u00e9n\u00e9ficient d'une meilleure tra\u00e7abilit\u00e9, de d\u00e9lais s\u00e9curis\u00e9s et d'un argument commercial de proximit\u00e9 appr\u00e9ci\u00e9 des patients.","inLanguage":"en-US"},"inLanguage":"en-US"}]}},"taxonomy_info":{"category":[{"value":10,"label":"Sant\u00e9"}]},"featured_image_src_large":["https:\/\/www.smartagents-healthcare.fr\/wp-content\/uploads\/2024\/07\/lindustrie-pharmaceutique-en-france-9629685-683x1024.jpg?wsr",683,1024,true],"author_info":{"display_name":"\u00c9quipe Smart Agents Healthcare","author_link":"https:\/\/www.smartagents-healthcare.fr\/en\/author\/highgy_admin\/"},"comment_info":3,"category_info":[{"term_id":10,"name":"Sant\u00e9","slug":"sante","term_group":0,"term_taxonomy_id":10,"taxonomy":"category","description":"","parent":0,"count":15,"filter":"raw","cat_ID":10,"category_count":15,"category_description":"","cat_name":"Sant\u00e9","category_nicename":"sante","category_parent":0}],"tag_info":false,"_links":{"self":[{"href":"https:\/\/www.smartagents-healthcare.fr\/en\/wp-json\/wp\/v2\/posts\/2444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.smartagents-healthcare.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.smartagents-healthcare.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.smartagents-healthcare.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.smartagents-healthcare.fr\/en\/wp-json\/wp\/v2\/comments?post=2444"}],"version-history":[{"count":21,"href":"https:\/\/www.smartagents-healthcare.fr\/en\/wp-json\/wp\/v2\/posts\/2444\/revisions"}],"predecessor-version":[{"id":3701,"href":"https:\/\/www.smartagents-healthcare.fr\/en\/wp-json\/wp\/v2\/posts\/2444\/revisions\/3701"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.smartagents-healthcare.fr\/en\/wp-json\/wp\/v2\/media\/2447"}],"wp:attachment":[{"href":"https:\/\/www.smartagents-healthcare.fr\/en\/wp-json\/wp\/v2\/media?parent=2444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.smartagents-healthcare.fr\/en\/wp-json\/wp\/v2\/categories?post=2444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.smartagents-healthcare.fr\/en\/wp-json\/wp\/v2\/tags?post=2444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}